Chemical Structure : Tosedostat
CAS No.: 238750-77-1
Catalog No.: PC-70071Not For Human Use, Lab Use Only.
Tosedostat (CHR-2797, CHR2797) is a potent, orally bioavailable aminopeptidases inhibitor with IC50 of 150, 220 and 100 nM for PuSA, aminopeptidase N and leucine aminopeptidase, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $98 | In stock | |
| 10 mg | $148 | In stock | |
| 25 mg | $268 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tosedostat (CHR-2797, CHR2797) is a potent, orally bioavailable aminopeptidases inhibitor with IC50 of 150, 220 and 100 nM for PuSA, aminopeptidase N and leucine aminopeptidase, respectively.
Tosedostat (CHR-2797) exerts antiproliferative effects against a range of tumor cell lines in vitro and in vivo and shows selectivity for transformed over nontransformed cells.
Tosedostat (CHR-2797) inhibits phosphorylation of mTOR substrates and reduces protein synthesis in HL-60 cells.
| M.Wt | 406.479 | |
| Formula | C21H30N2O6 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
cyclopentyl (S)-2-((R)-2-((S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methylpentanamido)-2-phenylacetate |
|
1. Krige D, et al. Cancer Res. 2008 Aug 15;68(16):6669-79.
2. Moore HE, et al. Mol Cancer Ther. 2009 Apr;8(4):762-70.
3. Reid AH, et al. Clin Cancer Res. 2009 Aug 1;15(15):4978-85.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright